|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/14 | |
| A61K 31/495 | |||
| A61K 38/26 | |||
| A61P 3/10 |
| (11) | Patento numeris | 2211842 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08841194.7 |
| Europos patento paraiškos padavimo data | 2008-10-24 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-08-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/081218 |
| Data | 2008-10-24 |
| (87) | Numeris | WO 2009/055740 |
| Data | 2009-04-30 |
| (30) | Numeris | Data | Šalis |
| 982368 P | 2007-10-24 | US | |
| 985620 P | 2007-11-05 | US | |
| 33740 P | 2008-03-04 | US | |
| 52127 P | 2008-05-09 | US |
| (72) |
RICHARDSON, Peter, US
BAUGHMAN, Robert, A., US
COSTELLO, Donald, US
|
| (73) |
MannKind Corporation,
25134 Rye Canyon Loop, Valencia CA 91355,
US
|
| (54) | AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION |
| AN INHALABLE DRY POWDER FORMULATION COMPRISING GLP-1 FOR USE IN THE TREATMENT OF HYPERGLYCEMIA AND DIABETES BY PULMONARY ADMINISTRATION |